» Articles » PMID: 15030772

Regulation of Dendritic Cell Trafficking by the ADP-ribosyl Cyclase CD38: Impact on the Development of Humoral Immunity

Overview
Journal Immunity
Publisher Cell Press
Date 2004 Mar 20
PMID 15030772
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Mice lacking CD38, an ectoenzyme that generates the calcium-mobilizing metabolite cADPR, make reduced T cell-dependent antibody responses. Despite the predicted role for CD38 in B cell activation, we find that CD38 regulates the migration of dendritic cell (DC) precursors from the blood to peripheral sites and controls the migration of mature DCs from sites of inflammation to lymph nodes. Thus, T cells are inefficiently primed in Cd38(-/-) mice, leading to poor humoral immune responses. We also show that CD38 and cADPR modulate calcium mobilization in chemokine-stimulated DCs and are required for the chemotaxis of immature and mature DCs to CCL2, CCL19, CCL21, and CXCL12. Therefore, CD38 regulates adaptive immunity by controlling chemokine receptor signaling in DCs.

Citing Articles

Liver X Receptors and Inflammatory-Induced C/EBPβ Selectively Cooperate to Control CD38 Transcription.

Glaria E, Martinez P, Font-Diaz J, De la Rosa J, Castrillo A, Crawshaw D J Innate Immun. 2024; 17(1):56-77.

PMID: 39701049 PMC: 11781815. DOI: 10.1159/000543274.


Homeostatic regulation of NAD(H) and NADP(H) in cells.

Chen L, Xing X, Zhang P, Chen L, Pei H Genes Dis. 2024; 11(5):101146.

PMID: 38988322 PMC: 11233901. DOI: 10.1016/j.gendis.2023.101146.


Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.

Rodriguez B, Chen L, Li Y, Miao S, Peng D, Fradette J Front Immunol. 2023; 14:1161869.

PMID: 37449205 PMC: 10336223. DOI: 10.3389/fimmu.2023.1161869.


The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy.

Stagg J, Golden E, Wennerberg E, Demaria S Sci Immunol. 2023; 8(85):eabq3015.

PMID: 37418547 PMC: 10394739. DOI: 10.1126/sciimmunol.abq3015.


A second-generation CD38-CAR-T cell for the treatment of multiple myeloma.

Li H, Li J, Wu J, Shi Z, Gao Y, Song W Cancer Med. 2023; 12(9):10804-10815.

PMID: 37039305 PMC: 10225187. DOI: 10.1002/cam4.5818.